Xtant Medical Holdings XTNT Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive)?
- Xtant Medical Holdings (XTNT) reported total cash, cash equivalents, and restricted cash (inclusive) of $12.16M in Q1 2026.
- How has Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
- Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive) increased by 123.7% year-over-year, from $5.44M to $12.16M.
- What is the long-term trend for Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive)?
- Over 5 years (2020 to 2025), Xtant Medical Holdings's total cash, cash equivalents, and restricted cash (inclusive) has grown at a 49.2% compound annual growth rate (CAGR), from $2.34M to $17.33M.
- What does total cash, cash equivalents, and restricted cash (inclusive) mean?
- This reflects the aggregate balance of cash, highly liquid investments, and restricted cash held by the company, including assets tied to discontinued operations. It provides a comprehensive view of the company's immediate liquidity and ability to meet short-term obligations.